These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6834988)

  • 1. Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites.
    Theodorou AE; Jenner P; Marsden CD
    Life Sci; 1983 Mar; 32(11):1243-54. PubMed ID: 6834988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cation regulation differentiates specific binding of [3H]sulpiride and [3H]spiperone to rat striatal preparations.
    Theodorou AE; Hall MD; Jenner P; Marsden CD
    J Pharm Pharmacol; 1980 Jun; 32(6):441-4. PubMed ID: 6106685
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons.
    Theodorou A; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1981 Jul; 33(7):439-44. PubMed ID: 6115030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of [3H]sultopride binding to rat brain.
    Mizuchi A; Kitagawa N; Saruta S; Miyachi Y
    Eur J Pharmacol; 1982 Oct; 84(1-2):51-9. PubMed ID: 6128237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of inhibitory activity of sulpiride for synaptic [3H]-spiperone binding in the rat striatum.
    Oki K; Nomura Y
    Dev Neurosci; 1982; 5(4):379-84. PubMed ID: 7140585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The characterization of [3H]sulpiride binding sites in rat striatal membranes.
    Imafuku J
    Brain Res; 1987 Feb; 402(2):331-8. PubMed ID: 3828800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sodium and sulphydryl groups on [3H]sulpiride binding sites in rat striatal membranes.
    Freedman SB; Poat JA; Woodruff GN
    J Neurochem; 1982 May; 38(5):1459-65. PubMed ID: 7062062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuroleptic binding characteristics in rat striatum and renal cortex.
    Hietala J; Syvälahti E; Röyttä M
    J Recept Res; 1988; 8(6):753-71. PubMed ID: 3193400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPS.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Pharm Pharmacol; 1985 May; 37(5):320-8. PubMed ID: 2862240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of [3H]zetidoline binding to rat striatal membranes.
    Barone D; Assandri A; Galliani G; Glässer A; Tarzia G
    J Pharm Pharmacol; 1985 Mar; 37(3):180-7. PubMed ID: 2858565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific [3H]piflutixol binding to CHAPS-solubilised rat striatal preparations involves dopamine D-2 but not D-1 binding sites.
    Kilpatrick GJ; Jenner P; Marsden CD
    J Neurochem; 1986 Feb; 46(2):413-21. PubMed ID: 3941314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride.
    Reader TA; Boulianne S; Molina-Holgado E; Dewar KM
    Biochem Pharmacol; 1990 Oct; 40(8):1739-46. PubMed ID: 2146961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of mono- and divalent ions on the binding of the adenosine analogue CGS 21680 to adenosine A2 receptors in rat striatum.
    Johansson B; Parkinson FE; Fredholm BB
    Biochem Pharmacol; 1992 Dec; 44(12):2365-70. PubMed ID: 1472101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The characterization of [3H]sulpiride binding sites in pig striatal membranes.
    Holden-Dye L; Poat JA; Senior K; Woodruff GN
    Biochem Pharmacol; 1985 Aug; 34(16):2905-9. PubMed ID: 4026877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.